Brian Taylor Slingsby - 20 Nov 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Signature
/s/ Brian Taylor Slingsby
Issuer symbol
MLYS
Transactions as of
20 Nov 2025
Net transactions value
-$43,350,000
Form type
4
Filing time
21 Nov 2025, 18:07:59 UTC
Previous filing
25 Apr 2025
Next filing
20 Feb 2026

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Slingsby Brian Taylor Director, 10%+ Owner 1700 WESTLAKE AVE. N, SUITE 200, THINKSPACE, SEATTLE /s/ Brian Taylor Slingsby 21 Nov 2025 0001963901
Catalys Pacific Fund, LP 10%+ Owner 3RD FLOOR WHITEHALL HOUSE, 238 NORTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS Catalys Pacific Fund, LP, By: Catalys Pacific Fund GP, LP, its General Partner, By: Catalys Pacific, LLC, its General Partner, By: /s/ Brian Taylor Slingsby, its Managing Director 21 Nov 2025 0001746274

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Sale $43,350,000 -1,000,000 -11% $43.35 7,903,838 20 Nov 2025 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.